Clinical Trial

Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer

Study acronym: ColoDix
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 1, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, multicenter, case-control study. The aim is to develop an optimized algorithm by combining the levels of molecular markers in plasma together with risk factors for developing colorectal cancer and clinical data of patients diagnosed with CRC or AA and healthy individuals.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-17.
Trial Details
NCT Number NCT06889883
Lead Sponsor ADVANCED MARKER DISCOVERY S.L.
Conditions Colorectal Carcinoma, Advanced Adenomas (AA)
Enrollment 510 participants
Start Date 2023-06-06
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-01